This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Northwest Biotherapeutics Inc (NWBO)

NASDAQ: Health Care

Company Profile
Price and Volume
Recent Price 4.70
52 Week High 12.55
52 Week Low 3.82
Avg. Daily Vol. (Mil) 0.48
Beta (3 year) 0.74
Share Related Items
Mkt Cap (Mil) 434.08
Shares Out (Mil) 92.36
Float (Mil) 33.17
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 0.10
Current Ratio 0.10
LT Debt/ Equity 0.00
Total Debt / Equity n.a.
Valuation Ratios
Price Earnings n.a.
Price/Sales 248.33
Price/Book 0.00
Price/Cash Flow -3.30
Per Share Data
Earnings -1.96
Sales 0.02
Book Value 0.00
Cash Flow -1.44
Business Summary
Northwest Biotherapeutics Inc is a development stage biotechnology company engaged in the development of immunotherapy products to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies.
General Information
4800 Montgomery Lane
Suite 800
Bethesda, MD 20814
Industry : Drugs
Sector: Health Care
Employees: 12
CEO: Ms. Linda F Powers
Short Interest
Current Month (Mil) 12.82
Previous Month (Mil) 12.87
Short Interest Ratio (Days) 19.00
Management Effectiveness
Return on Equity n.a.
Return on Assets -258.20
Return on Investments 373.00
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

NWBO Northwest Biotherapeutics Inc

Chart of NWBO

Analysts Ratings for NWBO

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

NWBO Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs